M. Giessing

Heinrich Heine University Düsseldorf

Papers

1

Total Citations

12

H-Index

1

About

M. Giessing is a leading urologic surgeon and researcher whose work centers on the surgical management of kidney tumours, with a particular focus on comparing open and robotic-assisted approaches. Their major contribution is the OpeRa trial, a landmark prospective, randomised, multicentre study that directly compares robotic-assisted partial nephrectomy (RAPN) to open partial nephrectomy (OPN) in patients with intermediate/high-complexity kidney tumours. This trial, published in 2025 and already garnering 12 citations, provides crucial evidence on whether robotic surgery reduces 30-day post-operative complications, addressing a key debate in urologic oncology. Giessing’s work has significant implications for surgical decision-making, helping to determine the optimal approach for complex cases. Their research is highly cited and influential, shaping clinical guidelines and practice. By leading this rigorous, randomised controlled trial, Giessing has made a notable contribution to evidence-based surgery, offering clarity on the benefits of robotic assistance in nephron-sparing surgery. Their work is essential reading for urologists, surgical oncologists, and researchers interested in minimally invasive techniques and patient outcomes.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Open versus robotic-assisted partial nephrectomy in patients with intermediate/high-complexity kidney tumours: final results of the randomised, controlled, open-label, multicentre trial OpeRa
12 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: Heinrich Heine University Düsseldorf

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago